- Home
- PHAT vs EQBK Comparison
PHAT vs EQBK Comparison
Compare PHAT & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- EQBK
- Stock Information
- Founded
- PHAT 2018
- EQBK 2002
- Country
- PHAT United States
- EQBK United States
- Employees
- PHAT N/A
- EQBK N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- EQBK Major Banks
- Sector
- PHAT Health Care
- EQBK Finance
- Exchange
- PHAT Nasdaq
- EQBK Nasdaq
- Market Cap
- PHAT 769.0M
- EQBK 800.2M
- IPO Year
- PHAT 2019
- EQBK 2015
- Fundamental
- Price
- PHAT $13.55
- EQBK $40.51
- Analyst Decision
- PHAT Strong Buy
- EQBK Buy
- Analyst Count
- PHAT 5
- EQBK 6
- Target Price
- PHAT $17.60
- EQBK $47.80
- AVG Volume (30 Days)
- PHAT 1.3M
- EQBK 109.2K
- Earning Date
- PHAT 10-30-2025
- EQBK 10-14-2025
- Dividend Yield
- PHAT N/A
- EQBK 1.78%
- EPS Growth
- PHAT N/A
- EQBK N/A
- EPS
- PHAT N/A
- EQBK 1.00
- Revenue
- PHAT $147,190,000.00
- EQBK $186,307,000.00
- Revenue This Year
- PHAT $213.65
- EQBK $12.71
- Revenue Next Year
- PHAT $91.41
- EQBK $41.13
- P/E Ratio
- PHAT N/A
- EQBK $40.37
- Revenue Growth
- PHAT 460.30
- EQBK 18.09
- 52 Week Low
- PHAT $2.21
- EQBK $34.11
- 52 Week High
- PHAT $19.50
- EQBK $50.85
- Technical
- Relative Strength Index (RSI)
- PHAT 58.66
- EQBK 47.18
- Support Level
- PHAT $13.02
- EQBK $40.15
- Resistance Level
- PHAT $16.08
- EQBK $42.34
- Average True Range (ATR)
- PHAT 1.05
- EQBK 1.40
- MACD
- PHAT -0.02
- EQBK 0.00
- Stochastic Oscillator
- PHAT 44.88
- EQBK 49.29
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.